VCEL Competitors & Alternatives
Compare Vericel Corp Ord with similar stocks in the same industry
Biotechnology
VCEL
Main Stock$47.49
Tradestie Score
61
Market Cap
$1.56B
P/E Ratio
109.3
Revenue Growth
0.3%
Analyst Upside
+16.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$31.00
|
$2.44B | - | 49 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$59.31
|
$2.42B | - | 54 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$147.03
|
$2.41B | - | 60 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$36.15
|
$2.40B | - | 57 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$27.12
|
$2.37B | - | 57 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$133.82
|
$2.35B | - | 57 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.79
|
$2.34B | - | 54 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$75.98
|
$2.33B | - | 64 | Compare |
More VCEL Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry